Need a Health professional?

Shreyaansh Lifesciences, Jaipur. India

Cemiplimab-rwlc Injection 350 mg
Cemiplimab-rwlc Injection is used to treat certain types of basal cell carcinoma and cutaneous squamous cell carcinoma that are locally advanced or have spread to other parts of the body.

Cemiplimab-rwlc Injection was approved for medical use in the United States in 2015. It is on the World Health Organization’s List of Essential Medicines.

Cemiplimab-rwlc Injection Available Price In India UK Saudi Arabia

Cemiplimab-rwlc Injection

  • API – Cemiplimab-rwlc
  • Packaging – Glass Bottle
  • Strength – 350 mg
  • Brand name Avalable – LIBTAYO

What is Cemiplimab-rwlc Injection used for?

Cemiplimab-rwlc Injection, Libtayo is a prescription medicine used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation.

    Disclaimer

    All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

    Get Access To Cemiplimab-rwlc Injection 350 mg

    Shreyaansh Lifesciences, Jaipur. India

    Shreyaansh Lifesciences is registered in Jaipur, India. Registration Number : 08AEEFS9350K1ZI under GST Act. 
    Branch Offices in India : Jaipur | New Delhi

    SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.

    +91 99292 77766

    Facts of Medicines

    Cemiplimab-rwlc Injection 350 mg

    HOW SUPPLIED/STORAGE AND HANDLING:

    Store at room temperature up to 25°C (77°F) for no more than 8 hours from the time of preparation to the end of the infusion or at 2°C to 8°C (36°F to 46°F) for no more than 24 hours from the time of preparation to the end of infusion.

    DOSAGE

    The recommended dosage of LIBTAYO is 350 mg administered as an intravenous infusion over 30 minutes every 3 weeks until disease progression or unacceptable toxicity.

    SIDE EFFECTS

    Some side effects may occur during the injection. Tell your caregiver right away if you feel dizzy, shaky, light-headed, nauseated, chilled or feverish, itchy, tingly, or have a rash, neck or back pain, trouble breathing, or swelling in your face.

    WARNINGS AND PRECAUTIONS

    • Genetic testing should be indicated in order to detect whether a person is at higher risk of developing hypersensitivity.
    • Cemiplimab-rwlc Injection may not be added as a single agent when antiretroviral regimens are changed because of loss of the virologic response.
    • Patients with liver disease should be watchful and cautious in order to Cemiplimab-rwlc Injection because it can aggravate the condition.
    • In patients with Cemiplimab-rwlc Injection, conditions like immune reconstitution inflammatory syndrome, a change in body fat as well as an increased risk of heart attack may occur.
    • Cemiplimab-rwlc Injection is not recommended for use in infants who are under 3 months of age.
    • Cases like lactic acidosis and severe hepatomegaly with steatosis occurred with the use of nucleoside analogues.
    • Sometimes serious hypersensitivity reactions have been associated with Cemiplimab-rwlc Injection.

    FAQs – Medicine Questions

    Cemiplimab-rwlc Injection 350 mg
    What is cemiplimab used for?
    A drug that binds to the protein PD-1 to help immune cells kill cancer cells better and is used to treat different types of cancer. Cemiplimab is used to treat certain types of basal cell carcinoma and cutaneous squamous cell carcinoma that are locally advanced or have spread to other parts of the body.
    What is RWLC in cemiplimab?
    Cemiplimab-rwlc injection is used to treat a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread (metastatic) or cannot be cured by surgery or radiation (locally advanced)
    How do you administer cemiplimab?
    The recommended dose is 350 mg cemiplimab every 3 weeks (Q3W) administered as an intravenous infusion over 30 minutes. Treatment may be continued until disease progression or unacceptable toxicity
    Where can I buy Cemiplimab-rwlc Injection?

    You can buy Cemiplimab-rwlc Injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

    The buyer should check the existing law in their home country before importing the product.

    What is the procedure to buy Cemiplimab-rwlc Injection?

    Patients can simply fill the order form or can send mail at info@treatmentoptions4u.com. Patients can also send WhatsApp messages to +91 99292 77766 / 98738 10020   We will reply ASAP with the details of theCemiplimab-rwlc Injection price as well as procurement procedure.

    Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

    NEWS / UPDATES